id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-0613-0003,FDA,FDA-2021-D-0613,Stability Testing for Medicated Premixes (Revision 1); VICH GL8(R); Guidance for Industry; Draft Guidance; #91,Other,Guidance,2026-04-16T04:00:00Z,2026,4,2026-04-16T04:00:00Z,2026-06-16T03:59:59Z,2026-04-16T20:09:33Z,,1,0,09000064b9287b2e
FDA-2021-D-0613-0002,FDA,FDA-2021-D-0613,"International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Stability Testing for Medicated
Premixes (Revision 1); Draft Guidance for Industry; Availability",Notice,Notice of Availability,2026-04-16T04:00:00Z,2026,4,,,2026-04-16T18:45:04Z,2026-07419,0,0,09000064b9286528
FDA-2021-D-0613-0001,FDA,FDA-2021-D-0613,CVM GFI #91 (VICH GL8) Stability Testing for Medicated Premixes,Other,Guidance,2021-07-26T04:00:00Z,2021,7,2021-07-26T04:00:00Z,,2024-11-06T23:49:06Z,,1,0,0900006484c0ee70